The growing practice of inhaling 5meo dimethyltryptamine in this country presents considerable hazards and complex legal concerns. Currently, 5MeO dimethyltryptamine remains a Controlled One substance under Canadian CDSA, causing its ownership and supply prohibited. While inhalation delivers the